Skip to main content
Top
Published in: Alzheimer's Research & Therapy 1/2015

Open Access 01-12-2015 | Research

Association of cognitive function with glucose tolerance and trajectories of glucose tolerance over 12 years in the AusDiab study

Authors: Kaarin J. Anstey, Kerry Sargent-Cox, Ranmalee Eramudugolla, Dianna J. Magliano, Jonathan E. Shaw

Published in: Alzheimer's Research & Therapy | Issue 1/2015

Login to get access

Abstract

Introduction

We investigated the association between glucose tolerance status and trajectories of change in blood glucose, and cognitive function in adults aged 25 to 85.

Methods

The sample (n = 4547) was drawn from a national, population-based cohort study in Australia (AusDiab). Fasting plasma glucose (FPG), glycated haemoglobin (HbA1c) and general health were assessed at 0, 5 and 12 years. Covariates included age, education, body mass index, blood pressure and physical activity. At 12 years, participants completed assessments of memory, processing speed and verbal ability.

Results

Known diabetes at baseline was associated with slower processing speed at 12 years in both younger (25–59 years) and older (>60 years) age-groups. After 12 years of follow-up, adults aged < 60 with diabetes at baseline had a mean speed score of 49.17 (SE = 1.09) compared with 52.39 (SE = 0.20) in normals. Among younger males without diagnosed diabetes, reduced memory at 12 years was associated with higher HbA1c at 5 years (β = −0.91, SE = 0.26, p < 0.001). No effects were apparent for females or older males. Adjusting for insulin sensitivity (HOMA-%S) and hs-C reactive protein attenuated these associations, but depression and CVD risk did not. Latent class analysis was used to analyse the associations between trajectories of HbA1C and glucose over 12 years, and cognition. Identified classes were described as 1) normal and stable blood glucose over time (reference), 2) high intercept but stable blood glucose over time, and 3) increasing blood glucose over time. In both young males and females, high stable glucose measures were associated with poorer cognitive function after 12 years.

Conclusion

Those with type 2 diabetes, younger males with high non-diabetic HbA1c, and adults with high stable blood glucose are at increased risk of poorer cognition. The findings reinforce the need for management of diabetes risk factors in midlife.
Appendix
Available only for authorised users
Literature
1.
go back to reference Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–81.PubMedCrossRef Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–81.PubMedCrossRef
2.
go back to reference Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. Plos One. 2009;4. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. Plos One. 2009;4.
4.
go back to reference Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69:1170–5.PubMedCentralPubMedCrossRef Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69:1170–5.PubMedCentralPubMedCrossRef
5.
go back to reference Biessels GJ, Strachan MWJ, Visseren FLJ, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2:246–55.PubMedCrossRef Biessels GJ, Strachan MWJ, Visseren FLJ, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2:246–55.PubMedCrossRef
6.
go back to reference Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7:184–90.PubMedCrossRef Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7:184–90.PubMedCrossRef
7.
go back to reference Winkler A, Dlugaj M, Weimar C, Jockel K-H, Erbel R, Dragano N, et al. Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women. J Alzheimers Dis. 2014;42:1269–77.PubMed Winkler A, Dlugaj M, Weimar C, Jockel K-H, Erbel R, Dragano N, et al. Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women. J Alzheimers Dis. 2014;42:1269–77.PubMed
8.
go back to reference Nooyens AC, Baan CA, Spijkerman AMW, Verschuren WMM. Type 2 diabetes and cognitive decline in middle-aged men and women. Diabetes Care. 2010;33:1964–9.PubMedCentralPubMedCrossRef Nooyens AC, Baan CA, Spijkerman AMW, Verschuren WMM. Type 2 diabetes and cognitive decline in middle-aged men and women. Diabetes Care. 2010;33:1964–9.PubMedCentralPubMedCrossRef
9.
go back to reference Karlamangla AS, Miller-Martinez D, Lachman ME, Tun PA, Koretz BK, Seeman TE. Biological correlates of adult cognition: Midlife in the United States (MIDUS). Neurobiol Aging. 2014;35:395-407. Karlamangla AS, Miller-Martinez D, Lachman ME, Tun PA, Koretz BK, Seeman TE. Biological correlates of adult cognition: Midlife in the United States (MIDUS). Neurobiol Aging. 2014;35:395-407.
10.
go back to reference Willette AA, Xu G, Johnson SC, Birdsill AC, Jonaitis EM. Insulin resistance, brain atrophy and cognitive performance in late middle-aged adults. Diabetes Care. 2013;36:443–9.PubMedCentralPubMedCrossRef Willette AA, Xu G, Johnson SC, Birdsill AC, Jonaitis EM. Insulin resistance, brain atrophy and cognitive performance in late middle-aged adults. Diabetes Care. 2013;36:443–9.PubMedCentralPubMedCrossRef
11.
go back to reference Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology. 2012;79:1019–26.PubMedCrossRef Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology. 2012;79:1019–26.PubMedCrossRef
12.
go back to reference Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Floel A. Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology. 2013. Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Floel A. Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology. 2013.
13.
go back to reference Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Godbold J, Sano M, et al. Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. Plos One. 2014;9, e97384.PubMedCentralPubMedCrossRef Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Godbold J, Sano M, et al. Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. Plos One. 2014;9, e97384.PubMedCentralPubMedCrossRef
14.
go back to reference Ravona-Springer R, Moshier E, Schmeidler J, Godbold J, Akrivos J, Rapp M, et al. Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. J Alzheimers Dis. 2012;30:299–309.PubMedCentralPubMed Ravona-Springer R, Moshier E, Schmeidler J, Godbold J, Akrivos J, Rapp M, et al. Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. J Alzheimers Dis. 2012;30:299–309.PubMedCentralPubMed
15.
go back to reference Tuligenga RH, Dugravot A, Tabak AG, Elbaz A, Brunner EJ, Kivimaki M, et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014;2:228–35.PubMedCentralPubMedCrossRef Tuligenga RH, Dugravot A, Tabak AG, Elbaz A, Brunner EJ, Kivimaki M, et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014;2:228–35.PubMedCentralPubMedCrossRef
16.
go back to reference Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract. 2002;57:119–29.PubMedCrossRef Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract. 2002;57:119–29.PubMedCrossRef
17.
go back to reference Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. In: Report of a WHO/IDF Consultation. Geneva: World Health Organization; 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. In: Report of a WHO/IDF Consultation. Geneva: World Health Organization; 2006.
18.
go back to reference Magliano DJ, Barr ELM, Zimmet PZ, Cemron AJ, Dunstan DW, Colagiuri S, et al. Glucose indices, health behaviors, and incidence of diabetes in Australia. Diabetes Care. 2008;31:267–72.PubMedCrossRef Magliano DJ, Barr ELM, Zimmet PZ, Cemron AJ, Dunstan DW, Colagiuri S, et al. Glucose indices, health behaviors, and incidence of diabetes in Australia. Diabetes Care. 2008;31:267–72.PubMedCrossRef
19.
go back to reference Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95.PubMedCrossRef Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95.PubMedCrossRef
20.
go back to reference Milnor WR. Cardiovascular physiology. New York: Oxford University Press; 1990. Milnor WR. Cardiovascular physiology. New York: Oxford University Press; 1990.
21.
go back to reference Australian Institute of Health and Welfare. The Active Australia Survey: a guide and manual for implementation, analysis and reporting. Edited by Welfare AIoHa. Canberra: Australian Institute of Health and Welfare; 2003. Australian Institute of Health and Welfare. The Active Australia Survey: a guide and manual for implementation, analysis and reporting. Edited by Welfare AIoHa. Canberra: Australian Institute of Health and Welfare; 2003.
22.
go back to reference Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. San Antonio: Psychological Corporation Harcourt Brace Jovanovich; 1987. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. San Antonio: Psychological Corporation Harcourt Brace Jovanovich; 1987.
23.
go back to reference Baddeley A, Emslie H, Nimmo-Smith I. The Spot-the-Word test. Bury St Edmunds: Thames Valley Test Company; 1992. Baddeley A, Emslie H, Nimmo-Smith I. The Spot-the-Word test. Bury St Edmunds: Thames Valley Test Company; 1992.
24.
go back to reference Smith A. Symbol Digit Modalities Test (SDMT) manual. Los Angeles: Western Psychological Services; 1982. Smith A. Symbol Digit Modalities Test (SDMT) manual. Los Angeles: Western Psychological Services; 1982.
25.
go back to reference Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef
26.
go back to reference Reijmer YD, Leemans A, Brundel M, Kappelle LJ, Biessels GJ. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes. 2013;62:2112–5.PubMedCentralPubMedCrossRef Reijmer YD, Leemans A, Brundel M, Kappelle LJ, Biessels GJ. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes. 2013;62:2112–5.PubMedCentralPubMedCrossRef
27.
go back to reference Mortby ME, Janke AL, Anstey KJ, Sachdev PS, Cherbuin N. High ‘normal’ blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the PATH through life study. PLoS One. 2013;8, e73697.PubMedCentralPubMedCrossRef Mortby ME, Janke AL, Anstey KJ, Sachdev PS, Cherbuin N. High ‘normal’ blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the PATH through life study. PLoS One. 2013;8, e73697.PubMedCentralPubMedCrossRef
28.
go back to reference Convit A, Wolf OT, Tarshish C, de Leon MJ. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A. 2003;100:2019–22.PubMedCentralPubMedCrossRef Convit A, Wolf OT, Tarshish C, de Leon MJ. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A. 2003;100:2019–22.PubMedCentralPubMedCrossRef
29.
go back to reference Launer LJ, Miller ME, Williamson JD. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–77.PubMedCentralPubMedCrossRef Launer LJ, Miller ME, Williamson JD. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–77.PubMedCentralPubMedCrossRef
30.
go back to reference Petrea RE, Beiser A, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham Heart Study. Stroke. 2009;40:1032–7.PubMedCentralPubMedCrossRef Petrea RE, Beiser A, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham Heart Study. Stroke. 2009;40:1032–7.PubMedCentralPubMedCrossRef
31.
go back to reference Sachdev P, Parslow R, Salonikas C, Lux O, Wen W, Kumar R, et al. Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men. Arch Neurol. 2004;61:1369–76.PubMedCrossRef Sachdev P, Parslow R, Salonikas C, Lux O, Wen W, Kumar R, et al. Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men. Arch Neurol. 2004;61:1369–76.PubMedCrossRef
32.
go back to reference Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948–58.PubMedCrossRef Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948–58.PubMedCrossRef
33.
go back to reference Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54:3003–6.PubMedCentralPubMedCrossRef Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54:3003–6.PubMedCentralPubMedCrossRef
34.
go back to reference Qui C, Zhang Y, Bronge L, Herlitz A, Aspelin P, Backman L, et al. Medial temporal lobe is vulnerable to vascular risk factors in men: a population-based study. Eur J Neurol. 2012;19:876–83.CrossRef Qui C, Zhang Y, Bronge L, Herlitz A, Aspelin P, Backman L, et al. Medial temporal lobe is vulnerable to vascular risk factors in men: a population-based study. Eur J Neurol. 2012;19:876–83.CrossRef
35.
go back to reference Greenwood CE, Winocur G. High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging. 2005;26S:S42–5.CrossRef Greenwood CE, Winocur G. High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging. 2005;26S:S42–5.CrossRef
36.
go back to reference Convit A. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging. 2005;26S:S31–5.CrossRef Convit A. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging. 2005;26S:S31–5.CrossRef
Metadata
Title
Association of cognitive function with glucose tolerance and trajectories of glucose tolerance over 12 years in the AusDiab study
Authors
Kaarin J. Anstey
Kerry Sargent-Cox
Ranmalee Eramudugolla
Dianna J. Magliano
Jonathan E. Shaw
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Alzheimer's Research & Therapy / Issue 1/2015
Electronic ISSN: 1758-9193
DOI
https://doi.org/10.1186/s13195-015-0131-4

Other articles of this Issue 1/2015

Alzheimer's Research & Therapy 1/2015 Go to the issue